Trials / Conditions / Frontal Fibrosing Alopecia

Frontal Fibrosing Alopecia

15 registered clinical trials studyying Frontal Fibrosing Alopecia — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Deucravacitinib in the Treatment of Cicatricial Alopecias NCT07508488	Icahn School of Medicine at Mount Sinai	Phase 2
Not Yet Recruiting	Facial Papules in Frontal Fibrosing Alopecia (FFA) NCT07340671	University of Miami	N/A
Not Yet Recruiting	The Effectiveness of Hydroxychloroquine Versus Methotrexate in the Treatment of Frontal Fibrosing Alopecia in NCT07190534	Erasmus Medical Center	—
Withdrawn	Platelet Rich Plasma for Frontal Fibrosing Alopecia NCT03335228	University of Minnesota	N/A
Active Not Recruiting	A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA NCT06240351	University of Alabama at Birmingham	Phase 4
Completed	Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Stu NCT06202560	Institute of Dermatology, Thailand	N/A
Completed	a Retrospective Study on the Systemic Treatment of LPP and FFA NCT06512766	Erasmus Medical Center	—
Completed	A Trial to Assess the Effect of Delgocitinib Cream 20 mg/g on the Molecular Signature, Safety, and Efficacy in NCT05332366	LEO Pharma	Phase 2
Completed	Follicular Revival in Fibrosing Alopecia: Evaluating Use of Micro-needling NCT04342091	Yale University	N/A
Completed	Oral Low-Dose Naltrexone for Lichen Planopilaris and Frontal Fibrosing Alopecia NCT04409041	Washington University School of Medicine	Phase 2
Completed	Pain Outcomes Following Intralesional Corticosteroid Injections NCT03630198	Vanderbilt University Medical Center	Phase 4
Unknown	Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia NCT03422640	Bellevue Dermatology	Phase 4
Unknown	Design and Validation of a New Assessment Tool for Lichen Planopilaris NCT03082560	Massachusetts General Hospital	—
Completed	Role of Neurogenic Inflammation and Topical 6% Gabapentin Therapy in Symptomatic Scarring Alopecia NCT03346668	University of Minnesota	EARLY_Phase 1
Unknown	Study to Assess the Efficacy of Intralesional Corticosteroid on the Treatment of Frontal Fibrosing Alopecia NCT02467101	Rubina Alves	N/A